Compared to the control group (C-OE), the knockout of OLFML2A resulted in significantly slower tumor growth and reduced final tumor volume, whereas overexpression of OLFML2A led to accelerated tumor progression and increased tumor sizes (Figures 5A–D). This evidence concerns the gene OLFML2A and neoplasm.